NISA INVESTMENT ADVISORS, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$141,605
+73.4%
5,270
+130.1%
0.00%0.0%
Q2 2023$81,661
+160019.6%
2,290
+14.2%
0.00%
Q1 2023$51
-83.6%
2,005
-73.8%
0.00%
-100.0%
Q4 2022$311
-99.9%
7,667
+1.9%
0.00%0.0%
Q3 2022$253,000
-1.9%
7,526
+2.8%
0.00%0.0%
Q2 2022$258,000
+24.0%
7,324
+61.9%
0.00%
+100.0%
Q1 2022$208,000
-41.4%
4,524
-32.8%
0.00%
-66.7%
Q4 2021$355,000
-42.6%
6,734
-32.0%
0.00%
-25.0%
Q3 2021$618,000
-13.8%
9,904
+14.4%
0.00%0.0%
Q2 2021$717,000
+40.3%
8,658
+12.3%
0.00%
+33.3%
Q1 2021$511,000
-11.9%
7,708
+2.0%
0.00%
-25.0%
Q4 2020$580,000
+147.9%
7,558
+39.1%
0.00%
+100.0%
Q3 2020$234,000
+69.6%
5,435
+70.6%
0.00%
+100.0%
Q2 2020$138,000
-45.5%
3,185
-63.8%
0.00%
-66.7%
Q1 2020$253,000
-65.2%
8,810
-23.0%
0.00%
-50.0%
Q4 2019$726,000
+2403.4%
11,440
+1021.6%
0.01%
Q3 2019$29,000
+107.1%
1,020
+96.2%
0.00%
Q2 2019$14,000
+40.0%
5200.0%0.00%
Q1 2019$10,000
+66.7%
5200.0%0.00%
Q4 2018$6,000
-40.0%
5200.0%0.00%
Q3 2018$10,000
+42.9%
520
-86.3%
0.00%
Q1 2017$7,0003,8000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$33,272,17921.56%
Aquilo Capital Management, LLC 1,103,515$44,758,56816.81%
M28 Capital Management LP 143,900$5,836,5845.56%
WEALTH EFFECTS LLC 155,620$6,311,9513.60%
Evolutionary Tree Capital Management, LLC 92,095$3,735,3733.59%
Privium Fund Management B.V. 221,015$8,867,1223.36%
JOHNSON & JOHNSON 247,598$10,0432.92%
COMMODORE CAPITAL LP 462,111$18,7432.82%
Avidity Partners Management LP 1,375,000$55,770,0001.21%
Capital Impact Advisors, LLC 26,853$1,089,1581.06%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders